SN vs. HLN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, and NIOX
Should you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Haleon (HLN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), and NIOX Group (NIOX).
Smith & Nephew vs.
Haleon (LON:HLN) and Smith & Nephew (LON:SN) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability.
Haleon currently has a consensus target price of GBX 415, indicating a potential upside of 1.59%. Smith & Nephew has a consensus target price of GBX 4,607.50, indicating a potential upside of 300.48%. Given Smith & Nephew's higher possible upside, analysts clearly believe Smith & Nephew is more favorable than Haleon.
Haleon has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500.
Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.5%. Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.5%. Haleon pays out 50.5% of its earnings in the form of a dividend. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Smith & Nephew received 549 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 62.02% of users gave Smith & Nephew an outperform vote while only 29.73% of users gave Haleon an outperform vote.
In the previous week, Smith & Nephew had 1 more articles in the media than Haleon. MarketBeat recorded 9 mentions for Smith & Nephew and 8 mentions for Haleon. Haleon's average media sentiment score of 0.60 beat Smith & Nephew's score of 0.05 indicating that Haleon is being referred to more favorably in the media.
43.9% of Haleon shares are owned by institutional investors. Comparatively, 62.2% of Smith & Nephew shares are owned by institutional investors. 10.7% of Haleon shares are owned by insiders. Comparatively, 0.2% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.
Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.
Summary
Smith & Nephew beats Haleon on 11 of the 19 factors compared between the two stocks.
Get Smith & Nephew News Delivered to You Automatically
Sign up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Smith & Nephew Competitors List
Related Companies and Tools
This page (LON:SN) was last updated on 3/4/2025 by MarketBeat.com Staff
